鲁抗医药 (600789)
Shandong Lukang Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 89866.96
- Circulating A-Shares(W): 89866.96
- Earnings Per Share(RMB): 0.1600
- Net Assets Per Share(RMB): 4.4032
- Operating Revenue(W RMB): 462435.04
- Total Profit(W RMB): 18633.61
- **Net Profit Attributable to Parent(W RMB) **: 14119.62
- Net Profit Growth Rate(%): -59.32
- Weighted Return on Equity(%): 3.5700
- Operating Cash Flow Per Share(RMB): 0.3400
- Undistributed Profit Per Share(RMB): 1.3081
- Capital Reserve Per Share(RMB): 1.8896
2. Main Business
The main business covers:
- Chemical raw materials and preparations for pharmaceutical production
3. Company Basic Information
- Company Name: Shandong Lukang Pharmaceutical Co., Ltd.
- Listing Date: 1997-02-26
- Industry: Pharmaceutical Manufacturing
- Address: No. 88 Deyuan Road, Jining High-tech Zone, Shandong Province
- Website: https://www.lkpc.com/
- Company Profile: The company was exclusively established by Jining Antibiotics Factory in November 1992, initially converting its operating net assets into 107.8045 million state shares and privately placing 41.6138 million employee shares. In January 1996, foreign investment funds were converted into 57.8717 million legal person shares, and land use rights were converted into 11.36 million state shares. After the initial online pricing issuance on January 23, 1997, the total shares at listing were 298.65 million shares; the 41.6138 million internal employee shares were to be listed for trading after three years from the public share circulation period.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Hualu Holding Group Co., Ltd. | General Legal Person | 18589.66 | 20.69 |
| 2 | Hualu Investment Development Co., Ltd. | General Legal Person | 2810.81 | 3.13 |
| 3 | Fucheng Haifu Asset Management - Shandong Development Investment Holding Group Co., Ltd. - Fucheng Haifutong Xinyi No. 2 Single Asset Management Plan | Asset Management Plan | 880.00 | 0.98 |
| 4 | Southern China Securities 1000 Exchange Traded Open-End Index Securities Investment Fund | Fund | 657.81 | 0.73 |
| 5 | Hong Kong Securities Clearing Company Ltd. | Northbound Funds | 558.74 | 0.62 |
5. Concept Sectors
- Biological Vaccine
- Industrial Internet
- Hepatitis Concept
- Innovative Drugs
- Synthetic Biology
- Pet Economy
- DeepSeek
Remarks
- Data update date: 2025-10-30
- Data source: Public market information